Atlas Trials

Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations

RecordFirmDate
Retrospective Chart Review and Historical Comparison of Capmatinib vs. Standard of Care for German Adult Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring METex14 Mutations (NCT05796726)Novartis Pharmaceuticals2021-12-10

Track Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations automatically

Every clearance here is in the API, with alerts when new ones post.